In addition, individuals with this atypical form of diabetes are able to discontinue insulin therapy within 4–12 weeks following the index episode of DKA and maintain excellent, long-term glycemic control on treatment with oral agents alone [4, 6]. This evidence concerns the gene INS and diabetes mellitus.